Core Insights - The first edition of the "Commercial Health Insurance Innovative Drug Directory" includes 19 drugs from 18 innovative pharmaceutical companies, highlighting advancements in medical technology [1][2] Group 1: Characteristics of the Innovative Drug Directory - The directory emphasizes support for innovation, featuring drugs that are significant achievements in recent medical advancements, including CAR-T, TCE therapies, and bispecific antibodies [2] - It focuses on key areas of concern, including drugs for Alzheimer's disease, which aligns with the aging population trend, as well as treatments for rare diseases prevalent in children, such as Gaucher disease and neuroblastoma [2] - The directory delineates the boundary between basic medical insurance and commercial insurance, with basic insurance prioritizing safety and efficacy of established drugs, while commercial insurance leans towards cutting-edge innovative medications [2]